Nice work Tony - synergys abound between peptide/antibodies
Intersting i always hunched either Novartis or GSK would be next in line aswell which fits with Genmad's path. One thing i've always been curious about however is why they haven't inked with Boehringer Ingelheim over the years considering Dougie was highly ranked in their operations so presumably would still have vast connections within the business - gauging by number of discussions fair to assume thay are inline i just presumed would of likely been one of the earliest collabs.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |